Incidents of fraud at pharmaceutical giant Novartis that resulted in over $1 billion in fines worldwide might have been avoided if the company’s compliance team used data analytics to detect patterns, says Thomas Fox, a compliance evangelist and author. See Also:
Read full article on BankInfoSecurity.com